Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Damon Korb

Developmental - Behavioral Pediatrics Los Gatos, CA Medical Doctor

NPI 1164719498 CMS profile 52309

15951 Los Gatos Blvd, St. 6, Los Gatos, CA 95032

Open in the dashboard

General payments

$2,148

106 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Damon Korb of Los Gatos, CA is reported in the CMS Open Payments database as having received $2,148 across 106 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Developmental - Behavioral Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $165 8
2024 General $599 20
2023 General $356 18
2022 General $321 17
2021 General $238 12
2020 General $102 5
2019 General $367 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Damon Korb
  • Developmental - Behavioral Pediatrics median
  • Middle half of Developmental - Behavioral Pediatrics
  • National median

In program year 2025, general payments to Damon Korb were reported at $165. Among 160 Developmental - Behavioral Pediatrics profiles paid that year, the median was $77 and the middle half received between $27 and $211.

Show as a table
Year Damon Korb Developmental - Behavioral Pediatrics median Middle half National median
2019 $367 $106 $28–$315 $163
2020 $102 $55 $19–$181 $114
2021 $238 $96 $25–$343 $132
2022 $321 $86 $23–$235 $149
2023 $356 $71 $25–$348 $160
2024 $599 $74 $25–$237 $164
2025 $165 $77 $27–$211 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Tris Pharma Inc $500 27 payments
  2. Supernus Pharmaceuticals, Inc. $466 13 payments
  3. Ironshore Pharmaceuticals Inc. $402 20 payments
  4. Corium, Inc. $254 12 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $176 10 payments
  6. Neos Therapeutics, LP $148 11 payments
  7. Collegium Pharmaceutical, Inc. $94 5 payments
  8. Shire North American Group Inc $36 3 payments
  9. Vertical Pharmaceuticals, LLC $31 2 payments
  10. Arbor Pharmaceuticals, Inc. $25 2 payments
  11. Other $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,148 106 payments
Products named General payments · program years 2019–2025
  1. Qelbree Viloxazine Hydrochloride $322 6 payments
  2. Azstarys $254 12 payments
  3. JORNAY PM Central Nervous System Stimulant $240 12 payments
  4. Dyanavel XR Adhd $240 13 payments
  5. Dyanavel XR Adhd $185 11 payments
  6. Adzenys XR-ODT $148 11 payments
  7. COTEMPLA XR-ODT $148 11 payments
  8. JORNAY PM Central Nervous Stimulant ADHD $145 7 payments
  9. QELBREE Psychology $144 7 payments
  10. Jornay PM Adhd $94 5 payments
  11. Other $355 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

106 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Developmental - Behavioral Pediatrics in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record